Mock Appraisal Committee Meeting for Ibrutinib in RR MCL

    Activity: Consultancy, spin-outs, CPD & licensingConsultancy & ServicesResearch

    Period8 Jul 2016
    Work forJanssen-Cilag Ltd, United Kingdom
    Degree of RecognitionNational

    Keywords

    • Mantle Cell Lymphoma
    • Ibrutinib
    • NICE Technology Appraisal